tiprankstipranks
Trending News
More News >
Data Horizon Co., Ltd. (JP:3628)
:3628
Japanese Market
Advertisement

Data Horizon Co., Ltd. (3628) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3628

Data Horizon Co., Ltd.

(3628)

Rating:50Neutral
Price Target:
¥640.00
▲(9.78%Upside)
Data Horizon Co., Ltd. has a poor financial performance with significant challenges in revenue and profitability, impacting its overall score negatively. Despite strong technical indicators suggesting potential short-term gains, the negative valuation due to poor earnings remains a significant concern. The lack of earnings call data and notable corporate events means these areas did not influence the score.

Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)

Data Horizon Co., Ltd. Business Overview & Revenue Model

Company DescriptionData Horizon Co., Ltd. (3628) is a company specializing in healthcare data management and analytics. It operates in the healthcare information technology sector, providing services that optimize the management and utilization of medical records and data. Its core products and services include electronic health record (EHR) systems, data analytics solutions, and healthcare IT consulting services, aimed at enhancing the efficiency and efficacy of healthcare providers.
How the Company Makes MoneyData Horizon Co., Ltd. generates revenue primarily through the sale and licensing of its electronic health record (EHR) systems and healthcare data analytics solutions. The company earns income from subscription fees for its software services and consulting fees for providing IT solutions tailored to healthcare institutions. Its key revenue streams include direct sales to hospitals, clinics, and other healthcare providers, as well as long-term contracts for software maintenance and upgrades. Significant partnerships with healthcare organizations and government bodies also contribute to its financial performance, enabling the company to expand its reach and service offerings.

Data Horizon Co., Ltd. Financial Statement Overview

Summary
Data Horizon Co., Ltd. faces significant financial challenges, including declining revenues, negative profitability margins, and increasing leverage. The weak cash flow generation further exacerbates these issues, highlighting liquidity risks. The company needs strategic measures to enhance revenue growth and improve operational efficiency to stabilize its financial position.
Income Statement
35
Negative
The company exhibits a significant decline in revenue and profitability, with negative EBIT and net income margins for both TTM and annual data. Revenue growth has been inconsistent, and recent periods show a contraction in sales. The gross profit margin remains relatively high but is undermined by substantial operating losses.
Balance Sheet
42
Neutral
The balance sheet shows high leverage with a rising debt-to-equity ratio, indicating increased financial risk. Stockholders' equity has been declining, further affecting the equity ratio negatively. While total assets have grown, the increase in liabilities poses a challenge to financial stability.
Cash Flow
25
Negative
Cash flow statements reveal negative free cash flow in recent periods, with operating cash flow unable to cover capital expenditures. The company's cash generation ability is weak, with no positive free cash flow growth observed. This raises concerns about liquidity and the ability to sustain operations without external financing.
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Data Horizon Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price583.00
Price Trends
50DMA
535.02
Positive
100DMA
496.84
Positive
200DMA
472.13
Positive
Market Momentum
MACD
14.67
Positive
RSI
52.23
Neutral
STOCH
13.43
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Positive. The current price of 583 is above the 20-day moving average (MA) of 580.65, above the 50-day MA of 535.02, and above the 200-day MA of 472.13, indicating a neutral trend. The MACD of 14.67 indicates Positive momentum. The RSI at 52.23 is Neutral, neither overbought nor oversold. The STOCH value of 13.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3628.

Data Horizon Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
85
Outperform
¥7.70B11.89
9.52%16.07%72.83%
76
Outperform
¥5.09B12.31
4.52%23.59%122.48%
74
Outperform
¥15.36B8.87
0.64%-12.13%291.07%
50
Neutral
¥7.37B
16.49%-483.70%
46
Neutral
C$205.70M-3.34-23.14%2.45%20.79%-0.36%
45
Neutral
¥14.00B
-79.38%-1239.83%
43
Neutral
¥20.04B4,465.71
1.26%-7.98%-181.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3628
Data Horizon Co., Ltd.
577.00
26.00
4.72%
JP:3671
Softmax Co., Ltd. (Japan)
315.00
124.96
65.75%
JP:3902
Medical Data Vision Co.Ltd.
513.00
-24.62
-4.58%
JP:4172
TOWA Hi SYSTEM Co., Ltd.
2,285.00
693.95
43.62%
JP:4263
SUSMED,Inc.
892.00
339.00
61.30%
JP:6095
MedPeer, Inc.
698.00
99.61
16.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 11, 2025